Obid, Rahib .

HRN: 23-94-87  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/11/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
03/11/2024
04/07/2024
IV
250 Mg
Q24H
Infective Endocarditis
Waiting Final Action 
03/11/2024
BENZYL PENICILLIN 1MU (VIAL)
03/11/2024
04/01/2024
IV
3 Million Units
Q6
Infective Endocarditis
Waiting Final Action 
03/23/2024
BENZYL PENICILLIN 5MU (VIAL)
03/23/2024
03/30/2024
IV
3M Units
OD
Infective Endocarditis
Waiting Final Action 
03/23/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
03/23/2024
03/30/2024
IV
250mg
OD
Infective Endocarditis
Waiting Final Action 
03/18/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/18/2025
03/25/2025
IV
4.5gm
Q8h
Infectious Endocarditis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: